ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Sanqi Qushi Granule Alleviates Proteinuria and Podocyte Damage in NS Rat: A Network Pharmacology Study and in vivo Experimental Validation

Wang, Lijuan; Liu, Huoliang; Wang, Yi; Hong, XiaoFan; Huang, Xiaoyan; Han, Miaoru; Wang, Dan; Shan, Wenjun; Li, Ping; Gu, Haowen; Liu, Bo*; Bao, Kun*广东省人民医院; 广州医学院; 广州中医药大学
Drug Design Development and Therapy2023DOI: 10.2147/DDDT.S403617
34阅读
引用收藏
分享

摘要

Background: Nephrotic syndrome (NS) and its numerous complications remain the leading causes of morbidity and mortality globally. Sanqi Qushi granule (SQG) is clinically effective in NS. However, its potential mechanisms have yet to be elucidated.Methods: A network pharmacology approach was employed in this study. Based on oral bioavailability and drug-likeness, potential active ingredients were picked out. After acquiring overlapping targets for drug genes and disease-related genes, a component-targetdisease network and protein-protein interaction analysis (PPI) were constructed using Cytoscape, followed by GO and KEGG enrichment analyses. Adriamycin was injected into adult male Sprague-Dawley (SD) rats via the tail vein to establish NS model. Kidney histology, 24-hr urinary protein level, creatinine (Cr), blood urea nitrogen (BUN), triglyceride (TG), total cholesterol (TC), and low-density lipoprotein (LDL-C) level were assessed. Western blotting, immunohistochemistry, and TUNEL staining were applied.Results: In total, 144 latent targets in SQG acting on NS were screened by a network pharmacology study, containing AKT, Bax, and Bcl-2. KEGG enrichment analysis suggested that PI3K/AKT pathway was enriched primarily. In vivo validation results revealed that SQG intervention ameliorated urine protein level and podocyte lesions in the NS model. Moreover, SQG therapy significantly inhibited renal cells apoptosis and decreased the ratio of Bax/Bcl-2 protein expression. Moreover, we found that Caspase-3 regulated the PI3K/AKT pathway in NS rats, which mediated the anti-apoptosis effect.Conclusion: By combining network pharmacology with experimental verification in vivo, this work confirmed the treatment efficacy of SQG for NS. SQG protected podocyte from injury and inhibited kidney apoptosis in NS rats via the PI3K/AKT pathway at least partially.

学科与关键词

关键词
Sanqi Qushi granulenephrotic syndromepodocyte injurykidney apoptosisnetwork pharmacologyPI3KAKT pathway
相关
加载中…
  • Danshen injection induces autophagy in podocytes to alleviate nephrotic syndrome via the PI3K/AKT/mTOR pathway
    Chen, Junqi; Yuan, Shengliang; Zhou, Jie; Huang, Xiuye; Wu, Wenjia; Cao, Yiwen; Liu, Hong; Hu, Qinghong; Li, Xiaojie; Guan, Xueping; Yin, Simin; Jiang, Jiaying; Zhou, Yuan*; Zhou, Jiuyao*PHYTOMEDICINE, 2022, 107: 154477.被引 8
  • Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway (vol 12, 727874, 2021)
    Wang, Xiaowan; Liu, Jinchu; Tian, Ruimin; Zheng, Bidan; Li, Chuang; Huang, Lihua; Lu, Zhisheng; Zhang, Jing; Mao, Wei; Liu, Bo*; Bao, Kun*; Xu, Peng*Frontiers in Pharmacology, 2022, 13: 905693.
  • Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT
    Li, Run; Shi, Chunru; Wei, Cuiting; Wang, Chao; Du, Hongjian; Liu, Ran; Wang, Xu; Hong, Quan*; Chen, Xiangmei*PHYTOMEDICINE, 2023, 116: 154873.被引 1
查看全部 →

发表信息

论文状态
公开发表
期刊
Drug Design Development and Therapy
发表日期
2023
卷期
第 17 卷
页码
1847-1861
DOI
10.2147/DDDT.S403617
语言
ENGLISH
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81974565]; Special project of State Key Laboratory of Dampness Syndrome of Chinese Medicine [SZ2021ZZ36, SZ2021ZZ09, SZ2021ZZ33]; 2020 Guangdong Provincial Science and Technology Innovation Strategy Special Fund (Guangdong-Hong Kong-Macau Joint Lab) [2020B1212030006]; Natural Science Foundation of Guangdong Province [2022A1515011628, 2022A1515010103]; Basic and Applied Basic Research Project of Guangzhou [202201020488]; Special Fund for International Cooperation Base of Traditional Chinese Medicine of National Administration of Traditional Chinese Medicine [0610-2240NF021548]

作者

  • W

    Wang, Lijuan (第一作者)

    2 · guangzhou univ chinese med

  • L

    Liu, Huoliang

    guangzhou med univ

查看全部 12 位作者收起作者
  • W

    Wang, Yi

    2 · guangzhou univ chinese med

  • H

    Hong, XiaoFan

    2 · guangzhou univ chinese med

  • H

    Huang, Xiaoyan

    2 · guangdong prov hosp · guangzhou univ chinese med

  • H

    Han, Miaoru

    2 · guangzhou univ chinese med

  • W

    Wang, Dan

    2 · guangzhou univ chinese med

  • S

    Shan, Wenjun

    2 · guangzhou univ chinese med

  • L

    Li, Ping

    2 · guangdong prov hosp · guangzhou univ chinese med

  • G

    Gu, Haowen

    2 · guangzhou univ chinese med

  • L

    Liu, Bo (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

  • B

    Bao, Kun (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417